Regulatory News: Varian Medical Systems and RaySearch Laboratories are engaged in a
long-term strategic collaboration agreement in which RaySearch will
develop advanced software for integration into Varian's Eclipse(TM)
treatment planning system.
The collaboration involves a number of components aimed at
improving radiation treatments, such as products for radiobiological
optimization and optimization of conventional 3D-CRT treatments. The
first product from the collaboration was previously expected to be
released during 2008. This has been postponed and now the three
products for radiobiological evaluation, radiobiological optimization
and optimization of conventional 3D-CRT plans are all expected to be
available to clinicians during the first half of 2009.
"Varian is a very important partner to us and we are dedicating
substantial resources to our joint development project," says Johan
Lof, President and Chief Executive Officer of RaySearch. "The product
development is progressing well and the first three products are all
planned to be demonstrated at the upcoming trade shows and released
during the first half of next year," concludes Johan Lof.
ABOUT RAYSEARCH RaySearch Laboratories is a medical technology company that
develops advanced software solutions for improved radiation therapy of
cancer. RaySearch's products are sold through license agreements with
leading partners such as Philips, Varian, Nucletron, IBA Dosimetry and
TomoTherapy. Eight products have been released to date and RaySearch's
software is used at over 1,300 clinics in more than 30 countries. In
addition, existing license agreements cover more than 15 other
products that are scheduled to be launched in the coming years. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet
in Stockholm and the company is listed in the SmallCap segment on the
OMX Nordic Exchange Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com.
This information was brought to you by Cision
http://newsroom.cision.com
Regulatory News:
Varian Medical Systems and RaySearch Laboratories are engaged in a
long-term strategic collaboration agreement in which RaySearch will
develop advanced software for integration into Varian's Eclipse™
treatment planning system.
The collaboration involves a number of components aimed at improving
radiation treatments, such as products for radiobiological optimization
and optimization of conventional 3D-CRT treatments. The first product
from the collaboration was previously expected to be released during
2008. This has been postponed and now the three products for
radiobiological evaluation, radiobiological optimization and
optimization of conventional 3D-CRT plans are all expected to be
available to clinicians during the first half of 2009.
“Varian is a very important partner to us and
we are dedicating substantial resources to our joint development project,”
says Johan Löf, President and Chief Executive
Officer of RaySearch. “The product development
is progressing well and the first three products are all planned to be
demonstrated at the upcoming trade shows and released during the first
half of next year,” concludes Johan Löf.
ABOUT RAYSEARCH
RaySearch Laboratories is a medical technology company that develops
advanced software solutions for improved radiation therapy of cancer.
RaySearch’s products are sold through license
agreements with leading partners such as Philips, Varian, Nucletron, IBA
Dosimetry and TomoTherapy. Eight products have been released to date and
RaySearch’s software is used at over 1,300
clinics in more than 30 countries. In addition, existing license
agreements cover more than 15 other products that are scheduled to be
launched in the coming years. RaySearch was founded in 2000 as a
spin-off from Karolinska Institutet in Stockholm and the company is
listed in the SmallCap segment on the OMX Nordic Exchange Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com.
This information was brought to you by Cision http://newsroom.cision.com
|